Sign Up to like & get
recommendations!
0
Published in 2021 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2021.04.067
Abstract: Background The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) trial showed that rivaroxaban plus aspirin reduced major adverse cardiovascular events (MACE) in patients with chronic coronary artery disease (CAD) and/or peripheral artery disease (PAD).…
read more here.
Keywords:
risk;
chads2;
cha2ds2 vasc;
vasc chads2 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000008762
Abstract: Abstract We assessed the thromboembolic risks of atrial fibrillation (AF) patients who had undergone radiofrequency ablation (RFA) using the CHADS2-VASc risk scoring system and further investigated the patterns of warfarin use for thromboprophylaxis according to…
read more here.
Keywords:
stroke risks;
chads2;
chads2 vasc;
therapy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202011_23609
Abstract: OBJECTIVE There is a gap in the knowledge concerning oral anticoagulation (OAC) in atrial fibrillation (AF) patients with a non-high risk of stroke. CHA2DS2VASc and CHADS2 scores generated imprecise risk estimates for low risk patients.…
read more here.
Keywords:
risk;
patients low;
high risk;
reclassified high ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Kardiologia polska"
DOI: 10.33963/kp.15102
Abstract: BACKGROUND The CHADS2 and CHA2DS2-VASc scores were shown to predict mortality in atrial fibrillation patients. However, both pathophysiology and treatment outcomes of atrial fibrillation and typical atrial flutter (AFL) differ. Consequently, prognosis in AFL patients…
read more here.
Keywords:
chads2 cha2ds2;
mortality;
cha2ds2 vasc;
chads2 ... See more keywords